Mark Coleman

Insider profile

Currently holds a position at Axsome Therapeutics Inc

Performance

Overall performance
3.5

Performance over holding periods
4.2
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
11 91% Buy
34 71% Buy
47 69% Buy

Performance for realised trades
4.4
Average return 783%
Success rate 73%
Average holding period 220
Transactions 28

Positions

Position Company Period
Independent Director Axsome Therapeutics Inc Dec. 1, 2014 -

Mark Coleman's trades of Axsome Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-10 2026-06-10 PlS Planned sale
77,604 +44.3%
297.71
US$2,508,795
77,604 +44.3% 297.71 US$2,508,795
2026-06-10 2026-06-10 PlS Planned sale
5,898 +16.5%
350.74
US$2,580,222
5,898 +16.5% 350.74 US$2,580,222
2026-06-10 2026-06-10 PrS Proposed sale
60,788
359.64
US$4,919,465
60,788 359.64 US$4,919,465
2026-06-02 2026-06-02 PlS Planned sale
5,537 -15.8%
223.39
US$1,236,910
5,537 -15.8% 223.39 US$1,236,910
2026-06-02 2026-06-02 PrS Proposed sale
5,537
223.39
US$1,236,885
5,537 223.39 US$1,236,885
2026-06-02 2026-06-01 PlS Planned sale
6,000 -14.6%
230.30
US$1,381,800
6,000 -14.6% 230.30 US$1,381,800
2026-06-01 2026-06-01 PrS Proposed sale
6,000
230.30
US$1,381,798
6,000 230.30 US$1,381,798
2026-06-02 2026-05-29 PlS Planned sale
6,000 -12.7%
233.46
US$1,400,760
6,000 -12.7% 233.46 US$1,400,760
2026-05-29 2026-05-29 PrS Proposed sale
6,000
233.46
US$1,400,783
6,000 233.46 US$1,400,783
2026-02-27 2026-02-26 PlS Planned sale
25,000 -34.7%
161.11
US$4,027,750
25,000 -34.7% 161.11 US$4,027,750
2026-02-26 2026-02-26 PrS Proposed sale
25,000
161.11
US$4,027,636
25,000 161.11 US$4,027,636
2025-09-09 2025-09-08 B Purchase
488 +1.0%
127.40
US$62,171
488 +1.0% 127.40 US$62,171
2025-09-09 2025-09-08 B Purchase
287 +0.6%
127.30
US$36,535
287 +0.6% 127.30 US$36,535
2025-09-09 2025-09-08 B Purchase
800 +1.7%
127.20
US$101,760
800 +1.7% 127.20 US$101,760
2025-05-29 2025-05-28 PlS Planned sale
3,750 -7.4%
103.43
US$387,862
3,750 -7.4% 103.43 US$387,862
2025-05-28 2025-05-28 PrS Proposed sale
3,750
103.43
US$387,858
3,750 103.43 US$387,858
2025-05-29 2025-05-27 PlS Planned sale
3,750 -6.9%
105.47
US$395,512
3,750 -6.9% 105.47 US$395,512
2025-05-27 2025-05-27 PrS Proposed sale
3,750
105.47
US$395,501
3,750 105.47 US$395,501
2025-05-20 2025-05-20 PrS Proposed sale
3,000
107.49
US$322,473
3,000 107.49 US$322,473
2025-05-20 2025-05-20 S Sale
3,000 -5.3%
107.49
US$322,473
3,000 -5.3% 107.49 US$322,473
2024-05-29 2024-05-29 PrS Proposed sale
5,248
75.14
US$394,332
5,248 75.14 US$394,332
2024-05-29 2024-05-29 PlS Planned sale
5,248 -26.4%
75.14
US$394,333
5,248 -26.4% 75.14 US$394,333
2024-05-29 2024-05-28 PlS Planned sale
5,249 -20.9%
75.21
US$394,775
5,249 -20.9% 75.21 US$394,775
2024-05-28 2024-05-28 PrS Proposed sale
5,249
75.21
US$394,774
5,249 75.21 US$394,774
2023-09-15 2023-09-15 PrS Proposed sale
29,588
75.18
US$2,224,431
29,588 75.18 US$2,224,431
2023-09-15 2023-09-15 PlS Planned sale
18,572 -4.4%
75.18
US$1,396,189
18,572 -4.4% 75.18 US$1,396,189
2023-09-15 2023-09-15 PlS Planned sale
11,016 -30.5%
75.19
US$828,241
11,016 -30.5% 75.19 US$828,241
2021-11-22 2021-11-18 B Purchase
1,021 +0.2%
35.10
US$35,837
1,021 +0.2% 35.10 US$35,837
2021-11-22 2021-11-18 B Purchase
409 +0.1%
35.07
US$14,344
409 +0.1% 35.07 US$14,344
2021-05-13 2021-05-12 B Purchase
500 +0.1%
58.15
US$29,075
500 +0.1% 58.15 US$29,075
2019-06-27 2019-06-26 B Purchase
15,800 +2.4%
23.10
US$364,980
15,800 +2.4% 23.10 US$364,980
2019-06-27 2019-06-25 B Purchase
400 +0.1%
23.25
US$9,300
400 +0.1% 23.25 US$9,300
2019-05-15 2019-05-13 B Purchase
4,650 +0.7%
21.44
US$99,696
4,650 +0.7% 21.44 US$99,696
2019-03-21 2019-03-19 B Purchase
5,100 +inf%
12.18
US$62,118
5,100 +inf% 12.18 US$62,118